Brain, Vol 120, Issue 6 1067-1076, Copyright © 1997 by Oxford University Press
T Wei and SL Lightman
We investigated the basal and dynamic regulation of the hypothalamo-
pituitary-adrenal (HPA), hypothalamo-pituitary-thyroid (HPT) and
hypothalamo-pituitary-gonadal axes and prolactin secretion in 52 patients
with clinically definite multiple sclerosis. These patients also had
gadolinium enhanced brain MRI scans and were divided into
relapsing-remitting, secondary progressive and primary progressive
subgroups. These subgroups were compared with healthy controls and a group
of patients with other neurological diseases. The cortisol diurnal rhythm
was preserved in all groups of patients. The time- integrated cortisol
response to human corticotropin-releasing hormone (CRH) stimulation was
lower in the patients with secondary progressive multiple sclerosis,
compared with patients with primary progressive multiple sclerosis and
healthy subjects. The time-integrated beta- endorphin response to CRH was
greater in the patients with relapsing- remitting multiple sclerosis
compared with the others. Feedback regulation assessed by dexamethasone
suppression was normal. Serum testosterone was low in 24% of male multiple
sclerosis patients and oestradiol was low in 25% of pre-menopausal female
multiple sclerosis patients, whereas prolactin and the HPT function were
normal. Correlations with C-reactive protein (CRP) and MRI suggest that
activation of the HPA axis in multiple sclerosis patients is secondary to
an active inflammatory stimulus.
ARTICLES
The neuroendocrine axis in patients with multiple sclerosis
Department of Clinical Neurology, Institute of Neurology, London, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. S. Haussleiter, M. Brune, and G. Juckel Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment Therapeutic Advances in Neurological Disorders, January 1, 2009; 2(1): 13 - 29. [Abstract] [PDF] |
||||
![]() |
M. C. Ysrraelit, M. I. Gaitan, A. S. Lopez, and J. Correale Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis Neurology, December 9, 2008; 71(24): 1948 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kern and T. Ziemssen Review: Brain immune communication psychoneuroimmunology of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 6 - 21. [Abstract] [PDF] |
||||
![]() |
S. E. Dunn, S. S. Ousman, R. A. Sobel, L. Zuniga, S. E. Baranzini, S. Youssef, A. Crowell, J. Loh, J. Oksenberg, and L. Steinman Peroxisome proliferator-activated receptor (PPAR){alpha} expression in T cells mediates gender differences in development of T cell-mediated autoimmunity J. Exp. Med., February 19, 2007; 204(2): 321 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jefferies The neuropsychiatry of multiple sclerosis Adv. Psychiatr. Treat., May 1, 2006; 12(3): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matejuk, C. Hopke, A. A. Vandenbark, P. D. Hurn, and H. Offner Middle-Age Male Mice Have Increased Severity of Experimental Autoimmune Encephalomyelitis and Are Unresponsive to Testosterone Therapy J. Immunol., February 15, 2005; 174(4): 2387 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Tomassini, E Onesti, C Mainero, E Giugni, A Paolillo, M Salvetti, F Nicoletti, and C Pozzilli Sex hormones modulate brain damage in multiple sclerosis: MRI evidence J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 272 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gottschalk, T. Kumpfel, P. Flachenecker, M. Uhr, C. Trenkwalder, F. Holsboer, and F. Weber Fatigue and Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Multiple Sclerosis Arch Neurol, February 1, 2005; 62(2): 277 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z A Erkut, E Endert, I Huitinga, and D F Swaab Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis Multiple Sclerosis, June 1, 2002; 8(3): 229 - 236. [Abstract] [PDF] |
||||
![]() |
A. Stefferl, M. K. Storch, C. Linington, C. Stadelmann, H. Lassmann, T. Pohl, F. Holsboer, F. J. H. Tilders, and J. M. H. M. Reul Disease Progression in Chronic Relapsing Experimental Allergic Encephalomyelitis Is Associated with Reduced Inflammation-Driven Production of Corticosterone Endocrinology, August 1, 2001; 142(8): 3616 - 3624. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Voskuhl and K. Palaszynski Sex Hormones in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis Neuroscientist, June 1, 2001; 7(3): 258 - 270. [Abstract] [PDF] |
||||
![]() |
F. T. Bergh, T. Kümpfel, A. Grasser, R. Rupprecht, F. Holsboer, and C. Trenkwalder Combined Treatment with Corticosteroids and Moclobemide Favors Normalization of Hypothalamo-Pituitary-Adrenal Axis Dysregulation in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double Blind Trial J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1610 - 1615. [Abstract] [Full Text] |
||||
![]() |
F. de Assis Aquino Gondim and F. P Thomas Episodic hyperlibidinism in multiple sclerosis Multiple Sclerosis, February 1, 2001; 7(1): 67 - 70. [Abstract] [PDF] |
||||
![]() |
F. T. Bergh, T. Kumpfel, C. Trenkwalder, R. Rupprecht, and F. Holsboer Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS Neurology, September 1, 1999; 53(4): 772 - 772. [Abstract] [Full Text] [PDF] |
||||










